A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cance...

Update Il y a 4 ans
Reference:

A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers: REZOLVE

  • | Country :
  • Australia
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Advanced chemotherapy resistant gynaecological cancers ,Ascites

Links